Moss, Nelson S. http://orcid.org/0000-0002-0930-1681
Singh, Jolene M. http://orcid.org/0000-0002-7058-0624
Reiner, Anne S. http://orcid.org/0000-0002-1258-6112
Drago, Joshua Z.
Modi, Shanu
Seidman, Andrew D. http://orcid.org/0000-0002-5064-3966
Chandarlapaty, Sarat http://orcid.org/0000-0003-4532-8053
Ross, Dara S.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)
Article History
Received: 24 May 2023
Accepted: 10 October 2023
First Online: 23 October 2023
Competing interests
: The authors of this research deny financial or non-financial competing interests, and make the following disclosures: NSM: Consulting fees for advisory board participation: AstraZeneca; research funding (to institution): AstraZeneca and GT Medical Technologies. JZD: Consulting fees: AstraZeneca, Intellisphere, Biotheranostics, Genagon, AmMax Bio, NuProbe; speaking fees: Virology Education; research funding (to institution): AstraZeneca.